BMC Cancer 2007, 7:226 http://www.biomedcentral.com/1471-2407/7/226 HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001, 344:783-792. 44. Barlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A: Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two sepa- rate regions. Genes Chromosomes Cancer 1997, 20:372-376. 45. Mattfeldt T, Wolter H, Kemmerling R, Gottfried HW, Kestler HA: Cluster analysis of comparative genomic hybridization (CGH) data using self-organizing maps: application to pros- tate carcinomas. Anal Cell Pathol 2001, 23(1):29-37. 46. Ribeiro FR, Jeronimo C, Henrique R, Fonseca D, Oliveira J, Lothe RA, Teixeira MR: 8q gain is an independent predictor of poor sur- vival in diagnostic needle biopsies from prostate cancer sus- pects. Clin Cancer Res 2006, 12:3961-3970. 47. Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van Der Kwast TT, Schroder FH, Tanke HJ, van Dekken H: Molecular cytogenetic analysis of prostatic adenocarcino- mas from screening studies: early cancers may contain aggressive genetic features. Am J Pathol 2001, 158:399-406. 48. Sun J, Liu W, Adams TS, Sun J, Li X, Turner AR, Chang B, Kim JW, Zheng SL, Isaacs WB, Xu J: DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate 2007, 67:692-700. 49. van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, Lindeman J, Craanen ME, Bloemena E, Meuwissen SG, Baak JP, Kuipers EJ: Helicobacter pylori-related and -non-related gas- tric cancers do not differ with respect to chromosomal aber- rations. J Pathol 2000, 192:301-306. 50. Osterberg L, Akeson M, Levan K, Partheen K, Zetterqvist BM, Brannstrom M, Horvath G: Genetic alterations of serous bor- derline tumors of the ovary compared to stage I serous ovar- ian carcinomas. Cancer Genet Cytogenet 2006, 167:103-108. 51. Partheen K, Levan K, Osterberg L, Helou K, Horvath G: Analysis of cytogenetic alterations in stage III serous ovarian adenocar- cinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Genes Chromosomes Cancer 2004, 40:342-348. 52. Ghadimi BM, Grade M, Liersch T, Langer C, Siemer A, Fuzesi L, Becker H: Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res 2003, 9:1808-1814. 53. De Angelis PM, Stokke T, Beigi M, Flatberg G, Enger M, Haug K, Aass HC, Schjolberg A, Andresen PA, Ariansen S, Bo AS, Mjaland O, Clausen OP: Chromosomal 20q gain in the DNA diploid com- ponent of aneuploid colorectal carcinomas. Int J Cancer 2007. 54. Grade M, Becker H, Liersch T, Ried T, Ghadimi BM: Molecular cytogenetics: genomic imbalances in colorectal cancer and their clinical impact. Cell Oncol 2006, 28:71-84. 55. Terracciano L, Tornillo L: Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization. Pathologica 2003, 95:71-82. 56. Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Win- gen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L: Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Clin Gastro- enterol Hepatol 2006, 4:1283-1291. 57. Lau SH, Guan XY: Cytogenetic and molecular genetic altera- tions in hepatocellular carcinoma. Acta Pharmacol Sin 2005, 26:659-665. 58. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994, 54:4813-4817. 59. Richter H, Braselmann H, Hieber L, Thomas G, Bogdanova T, Tronko N, Zitzelsberger H: Chromosomal imbalances in post-cherno- byl thyroid tumors. Thyroid 2004, 14:1061-1064. 60. Chen X, Knauf JA, Gonsky R, Wang M, Lai EH, Chissoe S, Fagin JA, Korenberg JR: From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet 1998, 63:625-637. 61. Schulte KM, Niederacher D, An HX, Staudt S, Simon D, Beckmann MW, Goretzki PE: INT-2 gene amplification in differentiated human thyroid cancer. Exp Clin Endocrinol Diabetes 1996, 104(Suppl 4):101-104. 62. Yakut T, Schulten HJ, Demir A, Frank D, Danner B, Egeli U, Gebitekin C, Kahler E, Gunawan B, Urer N, Ozturk H, Fuzesi L: Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer 2006, 54:293-301. 63. Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VV: Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the fre- quent genetic changes in cervical carcinoma. BMC Cancer 2004, 4:5. 64. Koon N, Zaika A, Moskaluk CA, Frierson HF, Knuutila S, Powell SM, El-Rifai W: Clustering of molecular alterations in gastro- esophageal carcinomas. Neoplasia 2004, 6:143-149. 65. Bentz M, Bergerheim US, Li C, Joos S, Werner CA, Baudis M, Gnarra J, Merino MJ, Zbar B, Linehan WM, Lichter P: Chromosome imbal- ances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization. Cytogenet Cell Genet 1996, 75(1):17-21. 66. Hoglund M, Gisselsson D, Soller M, Hansen GB, Elfving P, Mitelman F: Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data. Cancer Genet Cytogenet 2004, 153:1-9. 67. Li X, Wang E, Zhao YD, Ren JQ, Jin P, Yao KT, Marincola FM: Chro- mosomal imbalances in nasopharyngeal carcinoma: a meta- analysis of comparative genomic hybridization results. J Transl Med 2006, 4:4. 68. Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sid- ransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q: The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony forma- tion. Oncogene 2007, 26:934-944. 69. El-Rifai W, Kamel D, Larramendy ML, Shoman S, Gad Y, Baithun S, El- Awady M, Eissa S, Khaled H, Soloneski S, Sheaff M, Knuutila S: DNA copy number changes in Schistosoma-associated and non- Schistosoma-associated bladder cancer. Am J Pathol 2000, 156:871-878. 70. Duerr EM, Chung DC: Molecular genetics of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab 2007, 21:1-14. 71. Bauer J, Bastian BC: [DNA copy number changes in the diagno- sis of melanocytic tumors]. Pathologe 2007. 72. Karhu R, Mahlamaki E, Kallioniemi A: Pancreatic adenocarcinoma – genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 2006, 45:721-730. 73. Lee JY, Park YN, Uhm KO, Park SY, Park SH: Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degener- ate oligonucleotide primed PCR-comparative genomic hybridization. J Korean Med Sci 2004, 19:682-687. 74. Coe BP, Lee EH, Chi B, Girard L, Minna JD, Gazdar AF, Lam S, MacAulay C, Lam WL: Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung can- cer cell lines. Genes Chromosomes Cancer 2006, 45:11-19. 75. Levan K, Partheen K, Osterberg L, Helou K, Horvath G: Chromo- somal alterations in 98 endometrioid adenocarcinomas ana- lyzed with comparative genomic hybridization. Cytogenet Genome Res 2006, 115:16-22. 76. Bryndorf T, Kirchhoff M, Larsen J, Andreasson B, Bjerregaard B, Westh H, Rose H, Lundsteen C: The most common chromo- some aberration detected by high-resolution comparative genomic hybridization in vulvar intraepithelial neoplasia is not seen in vulvar squamous cell carcinoma. Cytogenet Genome Res 2004, 106:43-48. 77. Burnworth B, Popp S, Stark HJ, Steinkraus V, Brocker EB, Hartschuh W, Birek C, Boukamp P: Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 2006, 25:4399-4412. 78. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 1993, 4:138-141. 79. Seruca R, Suijkerbuijk RF, Gartner F, Criado B, Veiga I, Olde-Weghuis D, David L, Castedo S, Sobrinho-Simoes M: Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet Cytogenet 1995, 82:140-145. Page 14 of 15 (page number not for citation purposes)